441 related articles for article (PubMed ID: 26796360)
1. Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2.
Tamura S; Suzuki-Inoue K; Tsukiji N; Shirai T; Sasaki T; Osada M; Satoh K; Ozaki Y
Blood; 2016 Mar; 127(13):1701-10. PubMed ID: 26796360
[TBL] [Abstract][Full Text] [Related]
2. CLEC-2 and podoplanin, partners again.
Fu J; Xia L
Blood; 2016 Mar; 127(13):1629-30. PubMed ID: 27034419
[TBL] [Abstract][Full Text] [Related]
3. New horizon in platelet function: with special reference to a recently-found molecule, CLEC-2.
Ozaki Y; Tamura S; Suzuki-Inoue K
Thromb J; 2016; 14(Suppl 1):27. PubMed ID: 27766053
[TBL] [Abstract][Full Text] [Related]
4. CLEC-2 stimulates IGF-1 secretion from podoplanin-positive stromal cells and positively regulates erythropoiesis in mice.
Otake S; Sasaki T; Shirai T; Tsukiji N; Tamura S; Takano K; Ozaki Y; Suzuki-Inoue K
J Thromb Haemost; 2021 Jun; 19(6):1572-1584. PubMed ID: 33774924
[TBL] [Abstract][Full Text] [Related]
5. [Peri-arteriolar megakaryopoietic microenvironment via reciprocal CLEC-2/PDPN axis in bone marrow].
Tamura S; Suzuki-Inoue K; Ozaki Y; Hayakawa F; Kojima T
Rinsho Ketsueki; 2019; 60(7):834-842. PubMed ID: 31391374
[TBL] [Abstract][Full Text] [Related]
6. C-type lectin-like receptor 2 specifies a functionally distinct subpopulation within phenotypically defined hematopoietic stem cell population that contribute to emergent megakaryopoiesis.
Kumode T; Tanaka H; Esipinoza JL; Rai S; Taniguchi Y; Fujiwara R; Sano K; Serizawa K; Iwata Y; Morita Y; Matsumura I
Int J Hematol; 2022 Mar; 115(3):310-321. PubMed ID: 35106701
[TBL] [Abstract][Full Text] [Related]
7. Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood.
Suzuki-Inoue K; Osada M; Ozaki Y
J Thromb Haemost; 2017 Feb; 15(2):219-229. PubMed ID: 27960039
[TBL] [Abstract][Full Text] [Related]
8. CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development.
Finney BA; Schweighoffer E; Navarro-Núñez L; Bénézech C; Barone F; Hughes CE; Langan SA; Lowe KL; Pollitt AY; Mourao-Sa D; Sheardown S; Nash GB; Smithers N; Reis e Sousa C; Tybulewicz VL; Watson SP
Blood; 2012 Feb; 119(7):1747-56. PubMed ID: 22186994
[TBL] [Abstract][Full Text] [Related]
9. The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis.
Sheng M; Sun R; Fu J; Lu G
BMC Cancer; 2024 Apr; 24(1):399. PubMed ID: 38561690
[TBL] [Abstract][Full Text] [Related]
10. Hypercholesterolemia impairs megakaryopoiesis and platelet production in scavenger receptor BI knockout mice.
Ouweneel AB; Hoekstra M; van der Wel EJ; Schaftenaar FH; Snip OSC; Hassan J; Korporaal SJA; Van Eck M
Atherosclerosis; 2019 Mar; 282():176-182. PubMed ID: 30278990
[TBL] [Abstract][Full Text] [Related]
11. Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2.
Acton SE; Astarita JL; Malhotra D; Lukacs-Kornek V; Franz B; Hess PR; Jakus Z; Kuligowski M; Fletcher AL; Elpek KG; Bellemare-Pelletier A; Sceats L; Reynoso ED; Gonzalez SF; Graham DB; Chang J; Peters A; Woodruff M; Kim YA; Swat W; Morita T; Kuchroo V; Carroll MC; Kahn ML; Wucherpfennig KW; Turley SJ
Immunity; 2012 Aug; 37(2):276-89. PubMed ID: 22884313
[TBL] [Abstract][Full Text] [Related]
12. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling.
Bertozzi CC; Schmaier AA; Mericko P; Hess PR; Zou Z; Chen M; Chen CY; Xu B; Lu MM; Zhou D; Sebzda E; Santore MT; Merianos DJ; Stadtfeld M; Flake AW; Graf T; Skoda R; Maltzman JS; Koretzky GA; Kahn ML
Blood; 2010 Jul; 116(4):661-70. PubMed ID: 20363774
[TBL] [Abstract][Full Text] [Related]
13. CLEC-2 in megakaryocytes is critical for maintenance of hematopoietic stem cells in the bone marrow.
Nakamura-Ishizu A; Takubo K; Kobayashi H; Suzuki-Inoue K; Suda T
J Exp Med; 2015 Nov; 212(12):2133-46. PubMed ID: 26552707
[TBL] [Abstract][Full Text] [Related]
14. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2.
Herzog BH; Fu J; Wilson SJ; Hess PR; Sen A; McDaniel JM; Pan Y; Sheng M; Yago T; Silasi-Mansat R; McGee S; May F; Nieswandt B; Morris AJ; Lupu F; Coughlin SR; McEver RP; Chen H; Kahn ML; Xia L
Nature; 2013 Oct; 502(7469):105-9. PubMed ID: 23995678
[TBL] [Abstract][Full Text] [Related]
15. Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation.
Mazharian A; Watson SP; Séverin S
Exp Hematol; 2009 Oct; 37(10):1238-1249.e5. PubMed ID: 19619605
[TBL] [Abstract][Full Text] [Related]
16. Heightened activation of embryonic megakaryocytes causes aneurysms in the developing brain of mice lacking podoplanin.
Hoover C; Kondo Y; Shao B; McDaniel MJ; Lee R; McGee S; Whiteheart S; Bergmeier W; McEver RP; Xia L
Blood; 2021 May; 137(20):2756-2769. PubMed ID: 33619517
[TBL] [Abstract][Full Text] [Related]
17. C-type lectin-like receptor (CLEC)-2, the ligand of podoplanin, induces morphological changes in podocytes.
Tanaka K; Tanaka M; Watanabe N; Ito M; Pastan I; Koizumi M; Matsusaka T
Sci Rep; 2022 Dec; 12(1):22356. PubMed ID: 36572741
[TBL] [Abstract][Full Text] [Related]
18. Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function.
Mazharian A; Mori J; Wang YJ; Heising S; Neel BG; Watson SP; Senis YA
Blood; 2013 May; 121(20):4205-20. PubMed ID: 23509158
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA NORAD regulates megakaryocyte differentiation and proplatelet formation via the DUSP6/ERK signaling pathway.
Wang Y; Lv Y; Jiang X; Yu X; Wang D; Liu D; Liu X; Sun Y
Biochem Biophys Res Commun; 2024 Jun; 715():150004. PubMed ID: 38678784
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation.
Nagahisa H; Nagata Y; Ohnuki T; Osada M; Nagasawa T; Abe T; Todokoro K
Blood; 1996 Feb; 87(4):1309-16. PubMed ID: 8608219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
